BiotechTube
Home/Priothera/Stephan Oehen
SO

Stephan Oehen

COO & Founder

Priothera

Therapeutic Areas

Hematological MalignanciesAcute Myeloid Leukemia (AML)

Priothera Pipeline

DrugIndicationPhase
Mocravimod (KRP203)Acute Myeloid Leukemia (AML) maintenance post-allogeneic hematopoietic cell transplantation (allo-HCT)Phase 3

Leadership Team at Priothera

FG
Florent Gros
Founder & CEO
DP
Dhaval Patel
Director
View full Priothera profile